M. Ernsting

Molecular Biology · 2013

A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Ernsting trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. H. Maeda
  3. C. Walkey
  4. Hideaki Nakamura
  5. Jun Fang
  6. Richard Hoogenboom
  7. Ricky T. Tong
  8. Peter Carmeliet
  9. Jonathan B. Olsen

Papers from M. Ernsting's perspective

Ordered by how strongly the researchers M. Ernsting trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
  3. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
  4. Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
  5. Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
  6. Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
  7. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. (Journal of the American Chemical Society)
  8. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. (Cancer Research)
  9. Mediating tumor targeting efficiency of nanoparticles through design. (Nano letters (Print))
  10. High interstitial fluid pressure — an obstacle in cancer therapy (Nature Reviews. Cancer)

Their papers